Targeting Sphingosine Kinases for the Treatment of Cancer

Keyphrases

• Selective Inhibitor 100%
• Cancer Treatment 100%
• Sphingosine Kinase 1 (SphK1) 100%
• Inflammation 50%
• In Cancer 50%
• Cancer Patients 50%
• Tumor Growth 50%
• Clinical Data 50%
• First-in-class 50%
• Isozymes 50%
• Sphingolipid Metabolism 50%
• Pathologic 50%
• Metabolic Pathway 50%
• ABC294640 50%
• Druggable Targets 50%
• Clinical Testing 50%
• Dual Inhibitor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Sphingosine Kinase 100%
• Tumor Growth 50%
• Inflammation 50%
• Sphingolipid 50%
• Opaganib 50%
• Isoenzyme 50%